Lantheus Holdings (LNTH) Acquisitions (2025)

Lantheus Holdings (LNTH) reported Acquisitions of -$165000.0 for Q3 2025, down 100.08% quarter-over-quarter from $219.1 million in Q2 2025.

Lantheus Holdings (LNTH) Acquisitions (2025) Analysis & Trends

Lantheus Holdings (LNTH) has 1 years of Acquisitions data on file, last reported at -$165000.0 in Q3 2025.

Acquisitions for Q3 2025 came in at -$165000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $218.9 million (up 337.87% YoY), and the FY2025 annual result was $268.9 million, changed N/A from the prior year.
Acquisitions declined to -$165000.0 in Q3 2025 per LNTH's latest filing, from $219.1 million in the prior quarter.
Over five years, Acquisitions peaked at $219.1 million in Q2 2025 and troughed at -$165000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	2.09 Bn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	137.87 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	-

Download Data